TNGX peer analysis
Tango Therapeutics (TNGX) against its competitors: price, today's move, 1-year return and market value side by side.
TNGX and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRV Acrivon Therapeutics | $1.57 | -9.77% | -22.66% | – |
| CCCC C4 Therapeutics | $3.14 | 6.44% | 30.38% | – |
| ERAS Erasca | $14.57 | 9.80% | 559.55% | – |
| FHTX Foghorn Therapeutics | $1.87 | -1.84% | -53.37% | – |
| IDYA IDEAYA Biosciences | $31.24 | 1.92% | 5.36% | $2.75B |
| NRIX Nurix Therapeutics | $15.07 | 1.55% | 23.48% | – |
| NUVB Nuvation Bio | $4.19 | 0.00% | -15.45% | – |
| PRLD Prelude Therapeutics | $3.60 | 1.27% | 158.63% | – |
| RLAY Relay Therapeutics | $18.88 | 11.06% | 183.97% | – |
| RVMD Revolution Medicines | $194.38 | 9.41% | 224.06% | $41.22B |
| TNGX Tango Therapeutics | $21.50 | 3.02% | 186.09% | – |
- TNGX's peers: ACRV (Acrivon Therapeutics), CCCC (C4 Therapeutics), ERAS (Erasca), FHTX (Foghorn Therapeutics), IDYA (IDEAYA Biosciences), NRIX (Nurix Therapeutics), NUVB (Nuvation Bio), PRLD (Prelude Therapeutics).
Updated 2026-11-07 11:56 UTC